Literature DB >> 12395146

Oligonucleotide-mediated gene repair at DNA level: the potential applications for gene therapy.

Chang-Mei Liu1, De-Pei Liu, Chih-Chuan Liang.   

Abstract

Mutations in gene sequence can cause many genetic disorders, and researchers have attempted to develop treatments or cures at the DNA level for these diseases. Several strategies including triple-helix-forming oligonucleotides (TFOs), chimeric RNA/DNA oligonucleotide (RDO), and short single-stranded oligodeoxynucleotide (ODN) have been used to correct the dysfunctional genes in situ in the chromosome. Experimental data from cells and animal models suggest that all these strategies can repair the mutations in situ at DNA level. More effective structures of oligonucleotide, efficient delivery systems, and gene correction efficiency should be improved. Development of these strategies holds great potentials for treatments of genetic defects and other disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395146     DOI: 10.1007/s00109-002-0366-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  5 in total

1.  Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase.

Authors:  Silke Leimkühler; Mathilde Charcosset; Philippe Latour; Claude Dorche; Soledad Kleppe; Fernando Scaglia; Irmina Szymczak; Petra Schupp; Rita Hahnewald; Jochen Reiss
Journal:  Hum Genet       Date:  2005-07-14       Impact factor: 4.132

2.  Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.

Authors:  Latha M Santhakumaran; Thresia Thomas; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

3.  Gene targeting in mouse embryos mediated by RecA and modified single-stranded oligonucleotides.

Authors:  Jee Hyun Kang; Kwang Sung Ahn; Soon Young Heo; Ji Young Won; Hosup Shim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-02-12       Impact factor: 2.416

4.  Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.

Authors:  Gyati Shilakari Asthana; Abhay Asthana; Dharm Veer Kohli; Suresh Prasad Vyas
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

5.  Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.

Authors:  Wendi V Rodrigueza; Michael J Woolliscroft; Abdul-Shukkur Ebrahim; Robert Forgey; Patrick J McGovren; Gerold Endert; Andreas Wagner; Danielle Holewa; Amro Aboukameel; Richard D Gill; Charles L Bisgaier; Richard A Messmann; Christopher E Whitehead; Elzbieta Izbicka; Robert Streeper; Michael C Wick; Gabriela Stiegler; C A Stein; David Monsma; Craig Webb; Mina P Sooch; Steffen Panzner; Ramzi Mohammad; Neal C Goodwin; Ayad Al-Katib
Journal:  Cancer Chemother Pharmacol       Date:  2014-05-16       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.